Jagsonpal Pharmaceuticals Limited — Others, 08-05-2025: Copy of Newspaper Publication

Jagsonpal Pharmaceuticals Limited has announced a board meeting on May 6, 2025, to consider the financial results for the quarter and half-year. Total income from operations increased to Rs. 2769.06 million from Rs. 2179.81 million the previous year. Profit before tax and exceptional items rose to Rs. 501.72 million from Rs. 298.69 million. Net profit after tax surged to Rs. 553.61 million from Rs. 224.63 million, with basic EPS at Rs. 8.26 compared to Rs. 3.40 last year. The board approved a final dividend of Rs. 2.50 per share, pending shareholder approval.